Core Research and Technology
Integrated Capabilities from Research and Development to Application
Excelsior Bio-System Incorporation’s Technical Capabilities | From Raw Materials, Platforms to Application Support
Allergen testing and in vitro diagnostic technologies are not a single testing method, but a complete technological system supported by multiple interconnected components, including raw material preparation, antigen development, testing platforms, performance validation, manufacturing quality, and application implementation.
Excelsior Bio-System Incorporation has long been dedicated to immunological testing and in vitro diagnostic technologies. From research and development to manufacturing and real-world applications, the company has gradually built comprehensive vertically integrated capabilities. Through this technological capability framework, it is possible to understand how the company ensures quality control from the very source of testing and extends its technology into diagnostic services, product development, and diverse application scenarios.
This page first presents an overview of the company’s overall technical foundation, and then guides users to further explore raw material preparation, protein microarrays, ELISA, rapid test reagents, and frequently asked questions about technology platforms.
Vertically Integrated Development Capabilities | Building a Stable Foundation from the Source of Diagnostics
Immunological diagnostics involve multiple critical stages. From antigen design and raw material preparation to platform development, each stage directly affects the final quality and stability of testing results. Through a vertically integrated R&D and manufacturing process, Excelsior Bio-System Incorporation has established a consistent and controllable technological system.
In other words, EBS does not only provide testing services at the application end; it also possesses full R&D and technical expertise across the entire value chain—from diagnostic raw materials, antigen and antibody development, and testing platform design to application implementation.
Multiple International Quality Certifications
Excelsior Bio-System Incorporation utilizes molecular biology and database analysis capabilities to perform antigen design and recombinant protein development. This enables optimization of antigen structure and stability, making them more suitable for downstream diagnostic platforms and reagent development needs.
This capability demonstrates that EBS is able to establish a technological foundation at the source of diagnostics, rather than only providing downstream testing services.
Explore Raw Materials and Antigen DevelopmentHigh-Quality Raw Material Preparation Capability | The Starting Point for Reliable Diagnostic Stability
For in vitro diagnostic reagents, raw materials are a key factor affecting testing stability and consistency. Excelsior Bio-System Incorporation has long been engaged in allergen protein raw material preparation, purification, and quality verification, ensuring control at the very beginning of the product lifecycle.
Excelsior Bio-System Incorporation is able to design appropriate allergen protein antigen combinations according to dietary habits and environmental exposure needs in different regions. Through raw material sourcing verification, protein purification, stability evaluation, and activity validation, the company establishes a solid raw material foundation for downstream diagnostic platforms.
This demonstrates that EBS’s diagnostic capabilities are not only built on testing platforms, but also on control over the quality of raw materials and antigens at the source.
Explore the Raw Material Preparation Technology Platform
Multi-Platform Diagnostic Technologies | Supporting Diverse Testing Needs
Excelsior Bio-System Incorporation integrates multiple in vitro diagnostic technology platforms and develops corresponding testing methods based on different testing purposes, application scenarios, and interpretation requirements. These platforms together form the foundation of the company’s technological applications and support downstream diagnostic services and product development for humans, dogs and cats, and livestock.
Protein Microarray Technology
Protein microarray technology is an important platform for Excelsior Bio-System Incorporation’s allergen testing, enabling simultaneous analysis of multiple allergen reactions on a single platform and improving testing efficiency and data completeness.
Through integrated technologies including antigen spotting, fluorescence detection, and signal analysis, Excelsior Bio-System Incorporation is able to convert multiple allergen response data into interpretable diagnostic information to support clinical and health management needs.
Explore the Protein Microarray Technology Platform →Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA is based on antigen–antibody binding reactions, generating signal changes through enzyme-substrate interactions. It is suitable for disease detection, quantitative immune response analysis, and related in vitro diagnostic reagent development.
Excelsior Bio-System Incorporation can select appropriate reaction formats and corresponding antigen–antibody combinations according to different products and intended uses, establishing a stable foundation for immunoassay applications.
Explore the ELISA Technology Platform →Rapid Testing and POCT Applications
Rapid testing technologies are mainly used in scenarios requiring immediate interpretation. By simplifying operational procedures, they provide preliminary results within a short time, making them suitable for on-site screening, frontline diagnosis, and rapid application needs.
Excelsior Bio-System Incorporation has capabilities in rapid test reagent development and key material preparation, including colloidal gold-related technologies. Depending on different testing targets and application scenarios, the company develops rapid diagnostic products with stability and ease of use.
Explore the Rapid Test Technology Platform →
Validation and Serum Database | Ensuring Research Outputs Are Verifiable
The stability of technology platforms cannot be evaluated solely by R&D design; it must be confirmed through validation data and testing processes. Excelsior Bio-System Incorporation has established an in-house serum database and indexing system to perform activity testing and performance validation of raw materials and products, supporting diagnostic product stability and consistency.
This demonstrates that the company’s technical capabilities extend beyond R&D to include validation, testing, and stability control throughout product development.
View Technology Platform FAQsIntegrated R&D, Manufacturing, and Commercialization | From Research to Real-World Application
Excelsior Bio-System Incorporation has an integrated system spanning R&D, manufacturing, and market application, enabling technological achievements to move from the laboratory to real-world use. This integration not only supports product development but also enables diagnostic services, technology transfer, and collaborative applications.
During product commercialization, a stable manufacturing environment and quality management system are essential foundations. Through accumulated experience in R&D, manufacturing, quality control, and application, Excelsior Bio-System Incorporation ensures that diagnostic technologies can be reliably transformed into scalable and applicable products and services.
Explore Quality Certifications & Awards
Comprehensive Diagnostic Services and Technical Application Support
Excelsior Bio-System Incorporation has established a central laboratory with long-term experience in diagnostics and applications, enabling technical support and application implementation services for partners.
From raw materials and antigen development to multi-platform diagnostics, serum database validation, manufacturing quality, and central laboratory applications, the company has gradually built a complete support system spanning from R&D to real-world diagnostic services.
These capabilities support diagnostic services, product development, and collaborative applications across different fields, enabling Excelsior Bio-System Incorporation to provide flexible technical integration and application support tailored to diverse needs.
